Adicet Bio, Inc.
ACET
$8.15
$0.040.43%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -40.39% | 34.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -32.35% | 14.07% | |||
| Operating Income | 32.35% | -14.07% | |||
| Income Before Tax | 33.66% | -13.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.66% | -13.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.66% | -13.63% | |||
| EBIT | 32.35% | -14.07% | |||
| EBITDA | 33.49% | -15.29% | |||
| EPS Basic | 35.99% | 37.60% | |||
| Normalized Basic EPS | 35.99% | 37.60% | |||
| EPS Diluted | 35.99% | 37.60% | |||
| Normalized Diluted EPS | 35.99% | 37.60% | |||
| Average Basic Shares Outstanding | 3.64% | 82.10% | |||
| Average Diluted Shares Outstanding | 3.64% | 82.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||